Elevance Health Inc

More Details of Elevance Health Inc Company

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Company Info

Company codeELV

Company nameElevance Health Inc

IPO dateOct 30, 2001

Founded at2001

CEOMs. Gail K. Boudreaux

Number of employees103158

Security typeOrdinary Share

Fiscal year-endOct 30

Address220 Virginia Avenue

CityINDIANAPOLIS

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code46204

Phone18003311476

Websitehttps://www.elevancehealth.com/

Company codeELV

IPO dateOct 30, 2001

Founded at2001

Company Executives

Name

Name/Position

Position

Shareholding

Change

Tallett (Elizabeth E)

Independent Chairman of the Board

10.29K

--

Mr. Ramiro G. Peru

Independent Chairman of the Board

8.74K

--

Mr. Antonio F. Neri

Independent Director

4.32K

--

Dr. Bahija Jallal, Ph.D.

Independent Director

4.19K

--

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Ms. Deanna D. Strable-Soethout

Independent Director

1.04K

--

Mr. Ryan M. Schneider

Independent Director

--

Mr. Peter D. (Pete) Haytaian

Executive Vice President and President, Carelon and CarelonRx

--

Mr. Ratnakar V. Lavu

Executive Vice President and Chief Digital Information Officer

--

Ms. Gail K. Boudreaux

President, Chief Executive Officer, Director

--

Name

Name/Position

Position

Shareholding

Change

Tallett (Elizabeth E)

Independent Chairman of the Board

10.29K

--

Mr. Ramiro G. Peru

Independent Chairman of the Board

8.74K

--

Mr. Antonio F. Neri

Independent Director

4.32K

--

Dr. Bahija Jallal, Ph.D.

Independent Director

4.19K

--

Mr. Ronald W. Penczek

Chief Accounting Officer, Controller

1.69K

+3.99%

Ms. Deanna D. Strable-Soethout

Independent Director

1.04K

--

Revenue Breakdown

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

Premiums

144.17B

0.00%

Product revenue

22.63B

0.00%

Service fees

8.41B

0.00%

Reconciliation

1.81B

0.00%

Operating revenue - affliated

0.00

0.00%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Premiums

144.17B

0.00%

Product revenue

22.63B

0.00%

Service fees

8.41B

0.00%

Reconciliation

1.81B

0.00%

Operating revenue - affliated

0.00

0.00%

Shareholder

Update time: Sat, Apr 26

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.46%

BlackRock Institutional Trust Company, N.A.

5.21%

State Street Global Advisors (US)

4.73%

T. Rowe Price Associates, Inc.

4.53%

Wellington Management Company, LLP

2.81%

Other

73.25%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.46%

BlackRock Institutional Trust Company, N.A.

5.21%

State Street Global Advisors (US)

4.73%

T. Rowe Price Associates, Inc.

4.53%

Wellington Management Company, LLP

2.81%

Other

73.25%

Type

Shareholder

Proportion

Investment Advisor

41.53%

Investment Advisor/Hedge Fund

41.06%

Pension Fund

2.68%

Hedge Fund

2.63%

Bank and Trust

2.52%

Research Firm

1.78%

Sovereign Wealth Fund

1.46%

Family Office

0.27%

Family Office

0.27%

Other

5.80%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

3056

212.78M

94.17%

-4.99M

2024Q4

3098

213.30M

93.78%

-5.08M

2024Q3

3004

212.78M

91.75%

-6.27M

2024Q2

2973

214.50M

92.28%

-4.31M

2024Q1

2940

212.64M

91.38%

-6.83M

2023Q4

2879

214.42M

91.26%

-6.60M

2023Q3

2767

215.95M

91.62%

-5.63M

2023Q2

2750

218.40M

92.12%

-4.32M

2023Q1

2729

219.91M

92.66%

-8.42M

2022Q4

2684

220.86M

92.46%

-8.53M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

21.38M

9.45%

+141.85K

+0.67%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

11.78M

5.2%

+200.94K

+1.74%

Dec 31, 2024

State Street Global Advisors (US)

10.68M

4.72%

-5.71K

-0.05%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.24M

4.52%

+459.21K

+4.70%

Dec 31, 2024

Wellington Management Company, LLP

6.36M

2.81%

+1.89M

+42.45%

Dec 31, 2024

Geode Capital Management, L.L.C.

4.96M

2.19%

+115.97K

+2.39%

Dec 31, 2024

Sanders Capital, LLC

4.69M

2.07%

+76.90K

+1.67%

Dec 31, 2024

Capital International Investors

3.88M

1.71%

+35.58K

+0.93%

Dec 31, 2024

First Eagle Investment Management, L.L.C.

3.23M

1.42%

+1.04M

+47.56%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

3.08M

1.36%

+28.53K

+0.94%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

iShares U.S. Healthcare Providers ETF

12.36%

Monarch Dividend Plus Index ETF

3.5%

First Eagle Global Equity ETF

3.41%

Brookstone Value Stock ETF

3.3%

GMO US Quality ETF

3.1%

Simplify Market Neutral Equity Long/Short ETF

3.07%

Eagle Capital Select Equity ETF

2.62%

NYLI Healthy Hearts ETF

2.6%

Invesco S&P 500 Enhanced Value ETF

2.26%

FT Cboe Vest Rising Dividend Achievers Target Inc

2.21%

iShares U.S. Healthcare Providers ETF

Proportion12.36%

Monarch Dividend Plus Index ETF

Proportion3.5%

First Eagle Global Equity ETF

Proportion3.41%

Brookstone Value Stock ETF

Proportion3.3%

GMO US Quality ETF

Proportion3.1%

Simplify Market Neutral Equity Long/Short ETF

Proportion3.07%

Eagle Capital Select Equity ETF

Proportion2.62%

NYLI Healthy Hearts ETF

Proportion2.6%

Invesco S&P 500 Enhanced Value ETF

Proportion2.26%

FT Cboe Vest Rising Dividend Achievers Target Inc

Proportion2.21%

Dividend

A total of 6.19B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 23, 2025

ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 25, 2025

Mar 10, 2025

Oct 17, 2024

ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024

Dec 05, 2024

Dec 20, 2024

Dec 05, 2024

Jul 17, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024

Sep 10, 2024

Sep 25, 2024

Sep 10, 2024

Apr 18, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 25, 2024

Jun 10, 2024

Jan 26, 2024

ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 22, 2024

Mar 07, 2024

Oct 18, 2023

ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023

Dec 06, 2023

Dec 21, 2023

Dec 05, 2023

Jul 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 22, 2023

Sep 07, 2023

Apr 19, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Jun 23, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 23, 2023

Jun 08, 2023

Jan 25, 2023

ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Mar 24, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 24, 2023

Mar 09, 2023

Oct 19, 2022

ELV.NB Final Cash Dividend of gross USD 1.28 paid on Dec 21, 2022 going ex on Dec 02, 2022

Dec 05, 2022

Dec 21, 2022

Dec 02, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

415.110USD

Elevance Health Inc

415.110

Overview

Company